Cardiovascular Disease Related Topics 
Science Daily - Heart Disease
FEBRUARY 7, 2025
Women who have experienced pregnancy complications have an increased risk of cardiovascular disease. The findings suggest that genes and shared environmental factors may influence the association between pregnancy complications and cardiovascular disease risk.
DAIC
MARCH 31, 2025
mg reduces the risk of major adverse cardiovascular events (MACE) and supports its use in the treatment of cardiovascular disease. mg)has potential to directly reduce inflammation, which plays a substantial role in the formation and progression of atherosclerotic plaque leading to heart disease, said Matthew J.
Medical Xpress - Cardiology
NOVEMBER 14, 2024
Excess cholesterol is known to form artery-clogging plaques that can lead to stroke, arterial disease, heart attack, and more, making it the focus of many heart health campaigns.
Frontiers in Cardiovascular Medicine
FEBRUARY 17, 2025
Globally, cardiovascular diseases (CVDs) are a leading cause of death as they are responsible for the loss of at least 17 million lives annually. It has been established that the pathogenesis of CVDs is strongly associated both with inflammation as well as with inflammatory markers (proteins, cytokines, amongst others).
Heart BMJ
FEBRUARY 26, 2025
Background Menopause is a timely opportunity to screen for cardiovascular disease (CVD) and intervene with healthier lifestyles. We investigated the association between premature/early menopause and the likelihood of CVD and whether a healthy lifestyle is associated with a lower likelihood of CVD in menopausal woman.
Frontiers in Cardiovascular Medicine
MARCH 18, 2025
The immune response plays a vital role in the development of cardiovascular diseases (CVDs). As a crucial component of the innate immune system, neutrophils are involved in the initial inflammatory response following cardiovascular injury, thereby inducing subsequent damage and promoting recovery.
Frontiers in Cardiovascular Medicine
MARCH 28, 2025
BackgroundThere is a growing body of evidence indicating that metabolites are associated with an increased risk of cardiovascular diseases (CVDs), the underlying causality of these associations remains largely unchallenged. After Bonferroni correction, causal associations were found to be significant with p-values less than 0.05.
Expert insights. Personalized for you.
70 
Let's personalize your content